The objective of this study was to determine rates of estrus and conception in lactating multiparous Holstein cows given 500 μg of cloprostenol intramuscularly after detection of the following ≥ 60 d after parturition: a solid corpus luteum (CL), a CL with a nonechodense cavity ≤ 20 mm in diameter (CLcav), a luteal cyst (cavity > 20 mm in diameter and a luteinized wall > 3 mm in diameter), or a follicular cyst (cavity > 20 mm and a luteinized wall ≤ 3 mm in diameter). The estrus rates were 335/419 (80.0%), 183/223 (82.1%), 170/182 (93.4%), and 44/87 (50.6%), respectively (P < 0.0001), and the conception rates 30 to 36 d after insemination among the estrous cows with an apparently normal mucus discharge were 130/285 (45.6%), 44/141 (31.2%), 39/79 (49.4%), and 19/30 (63.3%), respectively (P < 0.002). Compared with a solid CL, a CLcav did not affect the estrus rate but significantly reduced the conception rate (P < 0.05), and the estrus rates were significantly higher and lower in cows with a luteal or follicular cyst, respectively (P < 0.05).

Objective-To determine the response to neostigmine of the contractile activity of the jejunum and pelvic flexure and the effects of a continuous rate infusion (CRI) of neostigmine in horses. Animals-7 adult horses and tissue from 12 adult horses. Procedures-A CRI of neostigmine (0.008 mg/kg/h) or placebo was administered to 6 horses in a crossover study design. Gastric emptying was evaluated by the acetaminophen test. The frequency of defecation and urination and the consistency and weight of feces were recorded throughout the experiment. The effect of neostigmine on smooth muscle contractile activity was evaluated in tissues from the jejunum and pelvic flexure. The effect of neostigmine and acetylcholine after incubation with muscarinic receptor antagonists (atropine and DAU 5884) and an acetylcholinesterase inhibitor (edrophonium) was also investigated in vitro. Results-No difference was observed between neostigmine and placebo for time to reach peak plasma acetaminophen concentration and absorption rate constant. A CRI of neostigmine increased fecal production and frequency of urination. Neostigmine induced a dose-dependent increase of contractile amplitude in jejunum and pelvic flexure muscle strips. Incubation of muscle strips with atropine and DAU 5884 inhibited the response to acetylcholine and neostigmine. Incubation of smooth muscle strips from the jejunum with edrophonium increased the response to acetylcholine and had no effect on the response to neostigmine in vitro. Conclusions and Clinical Relevance-A CRI of neostigmine increased fecal production and urination frequency in horses. A CRI of neostigmine did not decrease gastric emptying. Neostigmine stimulated contractile activity of jejunum and pelvic flexure smooth muscle strips in vitro.

Objective-To determine the pharmacokinetics of tramadol hydrochloride (30 mg/kg) following twice-daily oral administration in Hispaniolan Amazon parrots (Amazona ventralis). Animals-9 healthy adult Hispaniolan Amazon parrots. Procedures-Tramadol hydrochloride was administered to each parrot at a dosage of 30 mg/kg, PO, every 12 hours for 5 days. Blood samples were collected just prior to dose 2 on the first day of administration (day 1) and 5 minutes before and 10, 20, 30, 60, 90, 180, 360, and 720 minutes after the morning dose was given on day 5. Plasma was harvested from blood samples and analyzed by high-performance liquid chromatography. Degree of sedation was evaluated in each parrot throughout the study. Results-No changes in the parrots’ behavior were observed. Twelve hours after the first dose was administered, mean +/- SD concentrations of tramadol and its only active metabolite M1 (O-desmethyltramadol) were 53 +/- 57 ng/mL and 6 +/- 6 ng/mL, respectively. At steady state following 4.5 days of twice-daily administration, the mean half-lives for plasma tramadol and M1 concentrations were 2.92 +/- 0.78 hours and 2.14 +/- 0.07 hours, respectively. On day 5 of tramadol administration, plasma concentrations remained in the therapeutic range for approximately 6 hours. Other tramadol metabolites (M2, M4, and M5) were also present. Conclusions and Clinical Relevance-On the basis of these results and modeling of the data, tramadol at a dosage of 30 mg/kg, PO, will likely need to be administered every 6 to 8 hours to maintain therapeutic plasma concentrations in Hispaniolan Amazon parrots.

Objective—To determine the pharmacokinetics and hemodynamic effects of trazodone after IV and oral administration in dogs and bioavailability after oral administration. Animals—6 adult Beagles. Procedures—Dogs received trazodone HCl (8 mg/kg) orally and IV in a randomized controlled crossover design. Blood samples were collected at various times after administration. Heart rates and indirectly measured blood pressures of dogs and plasma concentrations and pharmacokinetics of trazodone were determined. Results—Following IV administration, the mean ± SD elimination half-life, apparent volume of distribution, and plasma total body clearance were 169 ± 53 minutes, 2.53 ± 0.47 L/kg, and 11.15 ± 3.56 mL/min/kg, respectively. Following oral administration, the mean ± SD elimination half-life and absolute bioavailability were 166 ± 47 minutes and 84.6 ± 13.2%, respectively. Maximum plasma concentration following oral administration was 1.3 ± 0.5 μ/mL, and time to maximum plasma concentration was 445 ± 271 minutes. After IV administration, all dogs immediately developed transient tachycardia (184.3 ± 8.0 beats/min), and 3 of 6 dogs developed aggression. Increase in heart rate was significantly associated with increase in plasma drug concentration following IV administration. Conclusions and Clinical Relevance—Results of this study indicated oral administration of trazodone resulted in acceptable absolute bioavailability, with substantial variability in time to maximum plasma concentration. Individualized approaches in dosing intervals may be necessary for dogs receiving oral trazodone. An orally administered dose of 8 mg/kg was well tolerated in dogs; IV administration of a dose of 8 mg/kg caused substantial adverse effects, including tachycardia and behavior disinhibition.

PCV-2 associated disease and related losses occur commonly in high health status herds. With the advent of PCV-2 vaccines, these losses can be successfully reduced. In this study, there was a significant reduction (48%) in the mortality rate of the vaccinated pigs when&#xD;compared to the non-vaccinated pigs. Vaccination was conducted at day 21. In the vaccinated group, mortality was reduced from 5.25 % to 2.73%. This data indicates that the implementation of a PCV2 vaccination program can reduce the mortality rate of high health status pigs in Malaysia.

The rapid method for predicting palm kernel cake quality with near infrared reflectance spectroscopy was investigated. Chemical tests for moisture, ash, crude protein, crude fat, crude fibre, total digestible nutrients (TDN), nitrogen free extract (NFE), metabolisable energy (ME), calcium and phosphorous were time&#xD;consuming and involve high cost. This technology can save considerable time by testing all the parameters simultaneously;&#xD;however accurate calibration of the equipment is essential. Near infrared (NIR) partial least square (PLS) regression models for determination of several palm kernel cake quality parameters were&#xD;developed from NIRFlex Model N-500 (Buchi). In general, reliable prediction results were obtained for the TDN (SEP = 0.85 r2 = 0.99), NFE (SEP = 0.42 r2 = 0.97) and crude protein (SEP = 0.57 r2 = 0.98)&#xD;PLS regression models.

The small ruminant industry in Malaysia is plagued by several significant problems related to health and management. Due to the hot, wet tropical climate, parasitic, bacterial and viral diseases are rampant and conveniently spread and enhanced by poor management. The Veterinary Research Institute has initiated a working group to&#xD;identify and control critical diseases in small ruminants as an educational cum advisory programme for farmers on the lower economic rung so that productivity and profits may be heightened. Farms are attended to base on the complaint of high mortality and morbidity, whereby a complete and holistic approach to disease control is taken. All the farms sampled were in the vicinity of the laboratory&#xD;that is within 150 km radius. Samples collected were faeces, blood (serum and whole blood) and nasal swabs as well as water and feed samples. A questionnaire on the management practices as well as&#xD;history of the farm was recorded. Tests on all samples were conducted according to routine procedures. Results from this study&#xD;on 7 farms involving 175 goats and sheep revealed that the common parasitic diseases encountered are helminthiasis, coccidiosis and blood protozoans. More than 80% of the animals showed strongyle and coccidial infections. The prominent bacterial infections are Caseous Lymphadenitis (34.3%), Brucellosis (Brucella melitensis), Leptospirosis (1.7%), Melliodosis and QFever whereas the viral diseases are Caprine Arthiritis Encephalitis (1.1%) and Blue Tongue (15.4%). Early detection for these diseases is critical so that production losses can be minimised. Poor nutrition and hygiene is a contributing factor for the high incidence of disease in small&#xD;ruminants. Farmer awareness on latest farming methods and services provided also contributes to general wellbeing of animals. One of the outcomes of this programme is to create awareness and getting farmers to be independent and confident in problem solving with regards to management and disease in their herds.

This study was conducted with the aim of investigating the&#xD;effectiveness of Neem leaf extracts, Azaridachta indica, an indigenous medicinal plant, against helminths of goats. Two extracts were prepared with distilled water using two different techniques; that is, the Neem leaves Water Extract (NLWE) and decoction of Neem&#xD;leaves(NLD). This study was carried out using 20 goats from a government farm in Perak. The two extracts showed variable degrees of efficacy in naturally infected goats, as measured by faecal egg count. Further evaluation is required to establish the efficacy.